Artivion, Inc.

Today is Aortic Dissection Awareness Day. An aortic dissection is a tear in the inner layer of a weak area of your aorta. It's a life-threatening condition that requires immediate care. Artivion is proud to offer a range of products designed to treat aortic arch dissections. Watch the video below to learn more. #aorticdissection 👉 Discover more about Artivion's portfolio of products that treat aortic disease: https://bit.ly/3rGUHZj

The AMDS™️ device demonstrates clinical results in the treatment of acute DeBakey Type I aortic dissection (ADTI) complicated by malperfusion. Significantly reduced 30-day major adverse events (MAEs), include: - All cause mortality - Stroke - New onset renal failure requiring dialysis - Myocardial infarction - DANE (distal anastomotic new entry tear) This outstanding performance resulted in the recent FDA HDE approval of AMDS, now commercially available in the USA. Elevate the standard of care with AMDS: https://bit.ly/3QB89dT

In conjunction with Aortic Disease Awareness Month and in partnership with CTSnet, Artivion is proud to sponsor an important webinar: Data-Driven Valve Selection in Younger AVR Patients.Our expert panel features Marc Gerdisch, MD, S. Chris Malaisrie, MD, and Jordan P. Bloom, MD. 📅 September 25, 8am EST 👉 Register today: https://bit.ly/4n4h4TP

Next stop: 𝐂𝐨𝐩𝐞𝐧𝐡𝐚𝐠𝐞𝐧 for the 𝟑𝟗𝐭𝐡 𝐄𝐀𝐂𝐓𝐒 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 (Oct 9–11)! We’re bringing our 𝐧𝐞𝐱𝐭-𝐥𝐞𝐯𝐞𝐥 𝐚𝐨𝐫𝐭𝐢𝐜 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 to the stage and can’t wait to show you what’s ahead. 👉 Plan your time at EACTS with 𝐀𝐫𝐭𝐢𝐯𝐢𝐨𝐧 in mind, check out our events today! https://bit.ly/47vqR0u #EACTS2025 #cardiovascular #FET #ArtivionEMEA

Throughout Aortic Disease Awareness Month, we're putting a spotlight on the people and products that make a difference in the lives of people with aortic disease. Today, we recognize our Artivion employees. 🌍 Across the globe, our team shows tremendous dedication to our mission of advancing aortic technologies with purpose. You are true #aorticchampions. 💙💚 #AorticDisease #aorticdissection #AortaEd

We are proud to celebrate another milestone in advancing patient care. Congratulations to Sanford Zeigler, M.D., from the Medical University of South Carolina , for successfully implanting the first AMDS Hybrid Prosthesis in South Carolina. The AMDS Hybrid Prosthesis is the world’s first device designed to treat patients with acute DeBakey Type I aortic dissections with malperfusion. We are excited to see how AMDS continues to transform the treatment of aortic dissection and bring hope to patients and families worldwide.

It was great connecting with the attendees at the ECS Club Annual Meeting at St. Elizabeth Training & Education Center in Kentucky! Thank you to Dr. William Kent, Marc Gerdisch, MD, FACS, FACC, FHRS and Mr. Joseph Zacharias for leading our interactive breakfast symposium “Shifting Tides-The Rise of Mechanical Valves: Aortic & Mitral Valve Management in Patients <65" We also appreciate our surgeon proctors for an outstanding ELITE™ Learning Lab: Drs. Rochus Voeller, William Kent, Ashok Venkataraman, MD FACS, and Denis Bouchard.

In today's installment of Mitral Mondays, Dr. Vincent Gaudiani demonstrates how to perform an On-X Chord-X®️ chordal repair of a P1 prolapse. Watch the case here: https://bit.ly/3JN45Hx Upon assessment of the valve, stretched chords were found at P1 with a billowing leaflet. Therefore, the 16mm On-X Chord-X premade system was used to place three sets of chords from the posteromedial papillary muscle to P1. #mitralvalve #cardiacsurgery

💙 We love seeing how AMDS is shaping the future of care in the aortic space. Congratulations again, Dr. Beckmann & Dr. Attia!

Join us for a Breakfast Symposium at #ECSC2025: Shifting Tides – The Rise of the Mechanical Valve: Aortic & Mitral Valve Management in Patients < 65. 📅 Friday, September 5th, 8:00 AM EST 📍St. Elizabeth Healthcare, Northern Kentucky Don't miss it!